Effect of co-administration of OCA and VSL#3 on gut microbiota in MASLD mouse model

In this study, we aimed to investigate the effects of the concurrent administration of OCA and VSL#3 on gut microbiota in a MASLD-induced mouse model.

本研究旨在探究奥贝胆酸（Obeticholic Acid，OCA）与VSL#3联合给药对代谢功能障碍相关性脂肪性肝病（Metabolic Dysfunction-Associated Steatotic Liver Disease，MASLD）诱导的小鼠模型肠道菌群的影响。